       Document 0382
 DOCN  M9640382
 TI    Thyroid therapy in HIV-infected patients.
 DT    9604
 AU    Derry DM
 SO    Med Hypotheses. 1995 Aug;45(2):121-4. Unique Identifier : AIDSLINE
       MED/96104076
 AB    Ten HIV-positive patients were given thyroid hormone in pharmacological
       doses. Two patients that had CD4 counts of 200 or higher responded well
       with gain in weight, energy, endurance and well-being within 6 months.
       During the same period, their CD4 counts rose to within normal limits
       and remained there. One patient has been well for 3 years and the other
       for 1 year. Six other patients with counts below 200 have had variable
       clinical improvements during the first 6 months but no change in CD4
       counts. Thyroid therapy in pharmacological doses helps most patients
       with symptoms of fatigue or depression. At the same time, it may retard
       or prevent the progression from HIV infection to AIDS.
 DE    Acquired Immunodeficiency Syndrome/PREVENTION & CONTROL  Adult  Case
       Report  CD4 Lymphocyte Count  Depression  Fatigue  Homosexuality, Male
       Human  HIV Infections/DRUG THERAPY/PHYSIOPATHOLOGY  HIV
       Seropositivity/*DRUG THERAPY/IMMUNOLOGY  Male  Thyroid Function Tests
       Thyroid Hormones/*THERAPEUTIC USE  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

